Biotech Values

[DewDiligence]

…here is a [hypothetical] scenario no one else has broached: what if the FDA approves both m-copaxone and t-lovenox on the same day! I think MNTA share price skyrockets once the market actually takes into account what just happened with Copaxone…

Agreed—in your wildly unlikely scenario, MNTA’s share price would go up substantially, IMO.